Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares ELN 2022: diagnosis and management of acute myeloid leukaemia in adults, ELN 2022 risk classification, VIALE-A, Cytarabine + anthracycline ('7+3') and the tag subtype-page.
Shares WHO classification of haematolymphoid tumours, fifth edition: myeloid and histiocytic neoplasms, CD47 and SIRP-alpha blockade, Hypomethylating agents (azacitidine, decitabine), Decitabine and the tag subtype-page.
Shares WHO classification of haematolymphoid tumours, fifth edition: myeloid and histiocytic neoplasms, Cytarabine + anthracycline ('7+3'), Allogeneic stem cell transplantation, Azacitidine and the tag subtype-page.
Shares TP53-mutated (p53-abnormal), Allogeneic stem cell transplantation, Venetoclax, TP53 and the tag subtype-page.
Shares TP53-mutated (p53-abnormal), Allogeneic stem cell transplantation, TP53 and the tag subtype-page.
Shares SF3B1 mutation, Azacitidine and the tag subtype-page.
Shares SF3B1 mutation and the tag subtype-page.
Shares TP53-mutated (p53-abnormal), Venetoclax and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.